The global Oral Drug Delivery Market is witnessing substantial growth, driven by increasing demand for convenient drug administration, the rising burden of chronic diseases, and continuous innovation in pharmaceutical formulations. Oral drug delivery is one of the most commonly adopted methods of medication administration, offering patients an accessible and convenient way to receive treatment through tablets, capsules, liquids, and other oral dosage forms. Its advantages, including ease of administration, cost-effectiveness, and better patient acceptance, are encouraging pharmaceutical manufacturers to develop advanced oral drug delivery solutions. Furthermore, growing investments in pharmaceutical research, increasing demand for modified-release formulations, and advancements in drug delivery technologies are creating promising growth opportunities across the global pharmaceutical industry.

Market Overview

The global Oral Drug Delivery Market was valued at US$ 100.30 billion in 2024 and is projected to reach US$ 162.11 billion by 2031, expanding at a CAGR of 7.1% during 2025–2031, according to The Insight Partners. Market expansion is primarily supported by increasing adoption of oral medications, advancements in pharmaceutical formulation technologies, and favorable government initiatives and regulatory support. The growing need for effective and patient-friendly treatment options is further strengthening demand for oral drug delivery solutions.

Oral drug delivery technologies are evolving through innovations in controlled-release formulations, orodispersible tablets, and taste-masking technologies. Pharmaceutical companies are increasingly focusing on improving drug stability, bioavailability, absorption, and therapeutic performance. Additionally, developments in advanced polymers, encapsulation technologies, and innovative formulation techniques are contributing to the evolution of oral drug delivery systems.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00004207

Increasing Preference for Convenient Drug Administration

The growing preference for convenient and non-invasive medication administration is a major factor supporting the expansion of the Oral Drug Delivery Market. Oral medications are widely used because they are easy to administer and generally do not require injections, specialized equipment, or assistance from healthcare professionals. Tablets, capsules, and liquid formulations provide convenient treatment options for patients across different age groups.

The expansion of home healthcare and outpatient treatment services is further increasing the importance of oral medications. Pharmaceutical manufacturers are developing patient-friendly formulations to improve treatment convenience and medication adherence. These developments are creating new opportunities for companies offering innovative oral drug delivery technologies.

Advancements in Pharmaceutical Formulation Technologies

Continuous innovation in pharmaceutical formulation technologies is creating new growth opportunities in the Oral Drug Delivery Market. Manufacturers are investing in advanced drug delivery platforms, polymer-based formulations, and nanoparticle technologies to improve drug absorption, stability, and therapeutic performance.

Controlled-release formulations are gaining attention because they allow active pharmaceutical ingredients to be released gradually over a specified period. These technologies can help reduce dosing frequency and support improved treatment convenience. Furthermore, advancements in formulation engineering are helping pharmaceutical researchers address challenges associated with poor drug solubility and bioavailability.

Growing Adoption of Controlled-Release Drug Formulations

Controlled-release technology is emerging as an important development area within the Oral Drug Delivery Market. These formulations are designed to release medication gradually, helping maintain drug concentrations over a specified period and potentially reducing the number of doses required.

Pharmaceutical manufacturers are focusing on modified-release technologies to improve medication convenience and support treatment adherence. Innovations in polymer materials, drug encapsulation, and formulation development are contributing to the advancement of controlled-release oral medications. Increasing demand for advanced pharmaceutical products is expected to support further investment in these technologies.

Emerging Opportunities in Oral Biologic Drug Delivery

Research into oral biologic drug delivery is creating additional opportunities for pharmaceutical and biotechnology companies. Many biologic medicines are conventionally administered through injections because digestive enzymes and gastrointestinal conditions can affect the stability and absorption of complex biological molecules.

Researchers are exploring innovative approaches such as protective encapsulation, nanotechnology, and advanced polymer-based delivery systems to overcome these challenges. These developments may help improve the stability and delivery of selected biologically active compounds through oral administration. Continued research and technological progress could create new opportunities for advanced oral drug delivery solutions.

Supportive Regulatory Environment and Pharmaceutical Industry Development

Government initiatives and regulatory support are contributing to the development of the Oral Drug Delivery Market. Regulatory authorities establish quality, safety, and efficacy requirements for pharmaceutical products while providing frameworks for the evaluation and approval of innovative formulations.

The expansion of pharmaceutical manufacturing infrastructure and increasing support for generic medicines are also creating opportunities for market participants. Pharmaceutical companies are strengthening their production capabilities and investing in formulation research to meet growing demand for affordable and effective medications across developed and emerging economies.

Increasing Demand for Generic Oral Medicines

The growing need for affordable healthcare treatments is supporting demand for generic oral medications. Generic medicines provide alternatives to branded pharmaceutical products after meeting applicable regulatory and quality requirements. Their availability can improve access to treatment and contribute to healthcare affordability.

Pharmaceutical manufacturers are expanding their generic medicine portfolios and improving formulation capabilities to address changing market requirements. Patent expirations, growing healthcare expenditure, and increasing demand for cost-effective treatments are expected to create further opportunities for manufacturers operating in the oral pharmaceutical segment.

Top Players in the Oral Drug Delivery Market

The Oral Drug Delivery Market comprises pharmaceutical, biotechnology, and drug delivery technology companies involved in developing innovative formulations and advanced drug administration platforms. Key companies profiled in The Insight Partners' report include:

• Emisphere Technologies Inc.

• Merrion Pharmaceuticals Plc

• Oramed Pharmaceuticals

• Samyang Corporation

• Unigene Laboratories Inc.

• BD

• Chimerix Inc.

• Skyepharma

• Evonik Nutrition & Care GmbH

• Amcor Limited

Market Segmentation

By Type:

• Controlled Release: This segment includes formulations designed to release active pharmaceutical ingredients gradually over an extended period. Controlled-release technologies can help reduce dosing frequency and improve medication convenience.

• Orodispersible Tablets and Taste Masking: Orodispersible tablets are formulated to disintegrate rapidly in the mouth, providing an alternative for patients who have difficulty swallowing conventional tablets. Taste-masking technologies improve the palatability and acceptability of oral pharmaceutical formulations.

By Geography:

The market is geographically analyzed across North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa.

• North America: US, Canada, and Mexico.

• Europe: UK, Germany, France, Russia, Italy, and Rest of Europe.

• Asia Pacific: China, India, Japan, Australia, and Rest of Asia Pacific.

• South and Central America: Brazil, Argentina, and Rest of South and Central America.

• Middle East and Africa: South Africa, Saudi Arabia, UAE, and Rest of Middle East and Africa.

Future Outlook

The Oral Drug Delivery Market is expected to experience continued growth through 2031, supported by increasing demand for convenient medications, advancements in pharmaceutical formulations, and expanding investments in drug delivery research. With the market projected to reach US$ 162.11 billion by 2031, manufacturers are expected to focus on developing innovative technologies that improve drug stability, absorption, and patient convenience.

The growing adoption of controlled-release formulations, orodispersible tablets, taste-masking technologies, and advanced oral delivery platforms is likely to create new business opportunities. Research into nanotechnology, polymer-based formulations, and oral biologic delivery may further influence the development of next-generation pharmaceutical products.

Additionally, increasing demand for generic medicines, pharmaceutical manufacturing improvements, and strategic collaborations are expected to strengthen market development. Companies prioritizing formulation innovation, product quality, and patient-centered drug delivery solutions are likely to remain competitive in the evolving global Oral Drug Delivery Market.

Related Reports –

Oral Controlled Release Drug Delivery Technology Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031

About Us

The Insight Partners, we provide comprehensive analysis and insights into market trends that empower businesses to make informed decisions. Our reports are designed to equip stakeholders with the necessary information to navigate the complexities of various industries, including healthcare, technology, and finance. We are dedicated to delivering high-quality research that enables our clients to achieve their strategic objectives.

Contact Us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish